Healthcare

Chinese pharmas face price pressures from Indian entrants under GPO

The entrance of Indian players may cut prices further by 30%.

10 in 11 APAC healthcare groups saw negative shareholder returns in 2016-2018: Bain

Rising costs, evolving regulations and reimbursement pressure eroded profits.

APAC's employer medical benefit costs may rise 8.7% in 2020

This growth will be led by Malaysia and Thailand.

Singapore lost $1.04b to migraines in 2018

Patients who experienced it for four to 14 days per month lost an average of $14,860.

Temasek advances in bid for stake in $2.5b Metro Pacific hospital unit

This could potentially be the biggest healthcare deal in the Philippines.

IHH Healthcare buys Prince Court Medical Centre for $240m

The deal would give IHH a larger share in the medical tourism market in Klang Valley.

IHH Healthcare profits up 28% to $57.42m in Q2

Singapore and Malaysia’s EBITDA earnings grew 28% and 29%, respectively.

Chinese pharma sales to hit $268b by 2028: Fitch Solutions

The effects of regulatory change on the sales of patented medicine are expected to be mild.

Singapore telehealth firm inks deal with Vietnamese insurer

Bao Minh's customers can consult with a doctor on their phones.

Icon Group acquires Hong Kong oncology clinic SunTech Medical

It is keen to make inroads into the ageing city.

Sumitomo Dainippon Pharma to acquire 10% stake in Roivant for $3b

The pharma will assume ownership interests in five biopharma companies.

Childhood vaccination in Singapore to be subsidised in CHAS general practitioner clinics

Subsidies will available in both polyclinics and CHAS clinics by end-2020.

Singapore medical device output grew 4.2% in June

The industry outperformed the output of the manufacturing sector, which fell 6.9%.

94% of Singapore firms attach international medical plans to healthcare programmes

This comes as employees seek more comprehensive plans to reduce out-of-pocket costs.

VC-sourced healthcare funding in Asia fell 39% to $2.57b in Q2

China-based Weimai’s $155m funding round was one of the quarter’s notable deals.